UBS ASSET MANAGEMENT AMERICAS LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$5,516,816
-26.2%
133,741
-0.2%
0.00%
-50.0%
Q2 2023$7,478,1480.0%134,0410.0%0.00%0.0%
Q1 2023$7,478,148
+59.7%
134,041
+4.3%
0.00%
+100.0%
Q4 2022$4,682,357
-99.9%
128,495
-0.8%
0.00%0.0%
Q3 2022$3,688,531,000
-82.3%
129,513
-71.8%
0.00%
-81.8%
Q2 2022$20,785,226,000
-50.7%
459,342
-17.2%
0.01%
-38.9%
Q1 2022$42,200,061,000
-43.0%
554,753
+11.6%
0.02%
-35.7%
Q4 2021$74,052,334,000
-3.7%
497,129
-5.9%
0.03%
-12.5%
Q3 2021$76,907,005,000
-24.2%
528,280
+2.0%
0.03%
-25.6%
Q2 2021$101,425,556,000
+12.6%
517,953
+4.1%
0.04%
+7.5%
Q1 2021$90,086,234,000
+2.4%
497,714
-19.9%
0.04%
-2.4%
Q4 2020$87,948,892,000
+60.1%
621,108
+41.0%
0.04%
+36.7%
Q3 2020$54,925,405,000
+55.5%
440,531
+11.4%
0.03%
+36.4%
Q2 2020$35,311,476,000
+56.1%
395,381
+8.9%
0.02%
+37.5%
Q1 2020$22,621,663,000
-18.2%
362,992
+0.1%
0.02%
-5.9%
Q4 2019$27,639,635,000
+196.9%
362,487
+96.3%
0.02%
+183.3%
Q3 2019$9,308,023,000184,6830.01%
Other shareholders
10X GENOMICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 708,528$29,226,780100.00%
Meritech Capital Associates V L.L.C. 494,236$20,387,2356.48%
Sands Capital Ventures, LLC 481,770$19,873,0135.88%
Decheng Capital Management III (Cayman), LLC 359,554$14,831,6034.95%
Iron Triangle Partners LP 666,945$27,511,4814.02%
Endurant Capital Management LP 71,044$2,930,5652.63%
Brown Capital Management 3,081,105$127,095,5811.95%
RTW INVESTMENTS, LP 1,519,956$62,698,1851.32%
Parametrica Management Ltd 15,300$631,1251.06%
Capital Impact Advisors, LLC 14,821$611,3661.02%
View complete list of 10X GENOMICS INC shareholders